By Zach Kirkland Piper Jaffray reiterated their hold rating on shares of CONMED (NASDAQ:CNMD) in a research report released on Thursday morning. Piper Jaffray currently has a $51.00 price objective on the stock, up from their previous price objective of $47.00. CONMED (NASDAQ:CNMD) opened at